Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemotherapy with Oxaliplatin, Floxuridine, Docetaxel, and Leucovorin for Esophageal Cancer
NCT00448760Phase 2Completed
- Sponsor
- University of Miami
- Start
- Oct 2004
- Primary completion
- Apr 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, floxuridine, docetaxel in Esophageal adenocarcinoma (EAC), sponsored by University of Miami. Started Oct 2004; status: completed.
02
Drugs
oxaliplatinfloxuridinedocetaxel
03
Conditions
Esophageal adenocarcinoma (EAC)
Beyond the preview
Go deeper on NCT00448760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448760.